{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:00:15Z","timestamp":1770987615394,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7542,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1023\/a:1026422224980","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T16:45:40Z","timestamp":1068137140000},"page":"519-526","source":"Crossref","is-referenced-by-count":26,"title":["Dose-escalation of CHOP in non-Hodgkin's lymphoma"],"prefix":"10.1016","volume":"10","author":[{"given":"A.","family":"Santoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Balzarotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tondini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Giardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Latteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Rampinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bufalino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1026422224980_bb0010","first-page":"5810","article-title":"The chemotherapy of lymphomas: Looking back, moving forward-the Richard and Hinda Rosenthal foundation Award Lecture","volume":"47","author":"DeVita","year":"1987","journal-title":"Cancer Res"},{"key":"10.1023\/A:1026422224980_bb0015","first-page":"1727","article-title":"A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate","volume":"63","author":"Goldie","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1023\/A:1026422224980_bb0020","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1026422224980_bb0025","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-102-5-596","article-title":"MACOP-B for treatment of advanced non-Hodgkin\u2019s lymphoma","volume":"102","author":"Klimo","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1023\/A:1026422224980_bb0030","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199211053271903","article-title":"Comparison of a second generation regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin\u2019s lymphoma","volume":"327","author":"Gordon","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1026422224980_bb0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/bjc.1996.360","article-title":"A randomized study of a third generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin\u2019s lymphoma: A British National Lymphoma Investigation report","volume":"74","author":"Linch","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1026422224980_bb0040","series-title":"Important Advances in Oncology","first-page":"121","article-title":"The importance of dose intensity in outcome of chemotherapy","author":"Hryniuk","year":"1988"},{"key":"10.1023\/A:1026422224980_bb0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1200\/JCO.1991.9.2.339","article-title":"The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin\u2019s lymphoma","volume":"9","author":"Meyer","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1026422224980_bb0050","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.1990.8.6.963","article-title":"Prognostic significance of actual dose-intensity in diffuse large-cell lymphoma: Results of a three-structured survival analysis","volume":"8","author":"Kwak","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1026422224980_bb0055","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood.V80.6.1430.1430","article-title":"Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkn\u2019s lymphoma: A randomized controlled trial","volume":"80","author":"Pettengell","year":"1992","journal-title":"Blood"},{"key":"10.1023\/A:1026422224980_bb0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.annonc.a058619","article-title":"Prognostic significance of received relative dose intensity in non-Hodgkin\u2019s lymphoma patients: Application to LNH-87 protocol","volume":"4","author":"Lepage","year":"1993","journal-title":"Ann Oncol"},{"issue":"Suppl 3","key":"10.1023\/A:1026422224980_bb0065","first-page":"24","article-title":"Randomized comparison of MACOP-B wih CHOP for intermediate-grade non-Hodgkin\u2019s lymphoma: Long-term follow-up","volume":"7","author":"Wolf","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1026422224980_bb0070","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.1995.13.12.2916","article-title":"High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin\u2019s lymphoma: A dose-finding pilot study","volume":"13","author":"Shipp","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1026422224980_bb0075","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classification of non-Hodgkin\u2019s lymphomas: Summary and description of a Working Formulation for clinical usage","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1023\/A:1026422224980_bb0080","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jcp.40.9.995","article-title":"Histopathology and immunohistochemistry of peripheral T-cell lymphomas: A proposal for their classification","volume":"40","author":"Suchi","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1023\/A:1026422224980_bb0085","first-page":"1860","article-title":"Report of the committee on Hodgkin\u2019s disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1023\/A:1026422224980_bb0090","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1026422224980_bb0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/path.1711710205","article-title":"Antigen unmasking on formalin-fixed, paraffin-embedded tissue section","volume":"171","author":"Cattoretti","year":"1993","journal-title":"J Pathol"},{"key":"10.1023\/A:1026422224980_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1023\/A:1026422224980_bb0105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.1996.14.4.1275","article-title":"Phase I trial dose-escalation with growth-factor support in patients with previously untreated diffuse aggressive lymphomas: Determination of the maximum tolerated dose of ProMACE\u2013CytaBOM","volume":"14","author":"Gordon","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1026422224980_bb0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1200\/JCO.1993.11.5.943","article-title":"Effective therapy for poor prognosis non-Hodgkin\u2019s lymphoma with eight weeks of high-dose-intensity combination chemotherapy","volume":"11","author":"Waits","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1026422224980_bb0115","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1200\/JCO.1997.15.5.1722","article-title":"Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin\u2019s lymphoma","volume":"15","author":"Stoppa","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1026422224980_bb0120","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJM199312093292404","article-title":"Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin\u2019s lymphoma","volume":"329","author":"Meyer","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1026422224980_bb0125","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1200\/JCO.1997.15.5.1713","article-title":"CHOP may have been part of the beginning but certainly not the end: Issues in risk-related therapy of large-cell lymphoma","volume":"15","author":"Canellos","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1026422224980_bb0130","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone-marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1026422224980_bb0135","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1200\/JCO.1997.15.3.1131","article-title":"Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin\u2019s lymphoma: Updated results of the prospective study LNH87-2","volume":"15","author":"Haioun","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1026422224980_bb0140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM199705013361804","article-title":"High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma","volume":"336","author":"Gianni","year":"1997","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1023\/A:1026422224980_bb0145","first-page":"594a","article-title":"Failure of first-line inductive high-dose chemotherapy in poor-risk patients with aggressive lymphoma: Updated results of the randomized LNH93-3 study","volume":"90","author":"Reyes","year":"1997","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1023\/A:1026422224980_bb0150","first-page":"S177","article-title":"High-dose chemotherapy with autologous stem-cell transplantation in high-grade NHL: First analysis of a randomized multicenter study","volume":"21","author":"Kaiser","year":"1998","journal-title":"BMT"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419571897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419571897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/10\/5\/519\/19477439\/10-5-519.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T23:30:33Z","timestamp":1582241433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419571897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S0923753419571897"],"URL":"https:\/\/doi.org\/10.1023\/a:1026422224980","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}